Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.

Dean Fennell

doi:10.1002/ijc.22984

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.

Dean Fennell

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	2575-2577
Number of pages	3
Journal	International journal of cancer. Journal international du cancer
Volume	121(11)
Issue number	11
DOIs	https://doi.org/10.1002/ijc.22984
Publication status	Published - 01 Dec 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1002/ijc.22984

Cite this

@article{64bb0e23fd16492e8d506a86b7201df4,

title = "Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.",

author = "Dean Fennell",

year = "2007",

month = dec,

day = "1",

doi = "10.1002/ijc.22984",

language = "English",

volume = "121(11)",

pages = "2575--2577",

journal = "International journal of cancer. Journal international du cancer",

publisher = "John Wiley \& Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.

AU - Fennell, Dean

PY - 2007/12/1

Y1 - 2007/12/1

UR - https://www.scopus.com/pages/publications/35648996360

U2 - 10.1002/ijc.22984

DO - 10.1002/ijc.22984

M3 - Article

C2 - 17680556

VL - 121(11)

SP - 2575

EP - 2577

JO - International journal of cancer. Journal international du cancer

JF - International journal of cancer. Journal international du cancer

IS - 11

ER -

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this